Screener
LeMaitre Vascular LMAT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | (unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $3,236 | $3,646 |
| Accrued expenses | 22,880 | 29,411 |
| Acquisition-related obligations | 380 | 322 |
| Lease liabilities - short-term | 3,439 | 2,944 |
| Total current liabilities | 29,935 | 36,323 |
| Convertible senior notes, net | 169,091 | 168,645 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's accrued expenses?
- LeMaitre Vascular (LMAT) reported accrued expenses of $22.88M in Q2 2026.
- How has LeMaitre Vascular's accrued expenses changed year-over-year?
- LeMaitre Vascular's accrued expenses decreased by 0.4% year-over-year, from $22.98M to $22.88M.
- What is the long-term trend for LeMaitre Vascular's accrued expenses?
- Over 5 years (2020 to 2025), LeMaitre Vascular's accrued expenses has grown at a 10.9% compound annual growth rate (CAGR), from $17.53M to $29.41M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about LeMaitre Vascular's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude